Ranquilon

DRUG2 trials

Sponsors

Valenta Pharm JSC

Conditions

Adjustment DisordersAnxietyNeurasthenia

Phase 3

A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders

CompletedNCT05586789

Valenta Pharm JSCAdjustment Disorders, Anxiety, Neurasthenia

Start: 2022-10-12End: 2023-01-03Updated: 2023-07-27

Phase 4

Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders

RecruitingNCT06843044

Valenta Pharm JSCAdjustment Disorders, Anxiety, Neurasthenia

Start: 2025-01-13End: 2027-12-31Target: 250Updated: 2025-07-08